CSPC Innovation Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 482.01 M

CSPC Innovation Pharmaceutical Co., Ltd. Cash and Short-Term Investments is USD 482.01 M for the year ending December 31, 2023, a 51.49% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

CSPC Innovation Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 318.18 M, a 22.87% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 258.96 M, a 15.72% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 223.78 M, a 8.58% change year over year.
CSPC Innovation Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 206.10 M, a 806.35% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shenzhen Stock Exchange: 300765.SZ

CSPC Innovation Pharmaceutical Co., Ltd.

CEO	Mr. Feng Han
IPO Date	March 22, 2019
Location	China
Headquarters	No. 36, Fuqiang Western Road
Employees	1,887
Sector	Consumers Staples
Industries Non-Alcoholic Beverages Alcoholic Beverages Consumer Packaged Goods Drugstores & Retail Pharmacies Pharmaceuticals Soft Drinks & Sodas Tobacco

Description

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.

Key trends

Past 5 years